PHAX and neoplasm: As compared to control groups (UT and NTsiRNA) which showed negligible levels of PHAX expression in CD31positive ECs, in some blood vessels, (Figure 6A,a), a strong signal was seen in cultures treated with sunitinib alone mainly localised to tumour cells, CD31positive ECs, and in some infiltrating mononuclear cells (Figure 5A,e).